Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $11.06 Consensus PT from Brokerages

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have received a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $11.0625.

Several research analysts have recently issued reports on AVAH shares. Barclays raised their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a report on Friday, January 16th. Jefferies Financial Group increased their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research report on Tuesday, October 28th. William Blair assumed coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating on the stock. Truist Financial upped their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a report on Friday, December 5th.

Insider Buying and Selling

In other news, major shareholder Paul R. Vigano sold 1,500,000 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares in the company, valued at approximately $3,264,714. This represents a 80.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Matthew Buckhalter sold 18,340 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $143,969.00. Following the completion of the transaction, the chief financial officer directly owned 436,980 shares in the company, valued at $3,430,293. This trade represents a 4.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 4,511,547 shares of company stock valued at $40,376,776 over the last quarter. 7.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Balboa Wealth Partners boosted its stake in Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after buying an additional 2,007 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Aveanna Healthcare during the 4th quarter worth approximately $484,000. SG Americas Securities LLC boosted its position in shares of Aveanna Healthcare by 15.2% during the 4th quarter. SG Americas Securities LLC now owns 19,906 shares of the company’s stock valued at $163,000 after acquiring an additional 2,624 shares during the last quarter. Diversified Trust Co. grew its holdings in shares of Aveanna Healthcare by 78.2% in the fourth quarter. Diversified Trust Co. now owns 19,400 shares of the company’s stock valued at $158,000 after purchasing an additional 8,516 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Aveanna Healthcare by 32.4% in the third quarter. JPMorgan Chase & Co. now owns 209,491 shares of the company’s stock worth $1,858,000 after purchasing an additional 51,226 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Down 1.0%

Shares of AVAH opened at $9.13 on Friday. Aveanna Healthcare has a 1 year low of $3.67 and a 1 year high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The stock has a 50 day simple moving average of $8.84 and a two-hundred day simple moving average of $7.87. The firm has a market cap of $1.91 billion, a P/E ratio of 25.36 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.07 by $0.08. The firm had revenue of $621.94 million for the quarter, compared to the consensus estimate of $578.57 million. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, analysts forecast that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.